Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ABSTRACT


CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Stent placement in the superficial femoral and proximal popliteal arteries with the innova self-expanding bare metal stent system

Richard J. Powell MD, Michael R. Jaff DO, Herman Schroë MD, Andrew Benko MD, Juan Diaz-Cartelle MD, Stefan Müller-Hülsbeck MD

Objectives: The SuperNOVA trial was designed to evaluate performance of the Innova Vascular Self-Expanding Stent System (Boston Scientific, Marlborough, MA) for treating lesions in the femoropopliteal arteries.

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Midterm outcomes of orbital atherectomy combined with drug-coated balloon angioplasty for treatment of femoropopliteal disease

T. Raymond Foley MD, Ryan P. Cotter MD, Damianos G. Kokkinidis MD, Daniel D. Nguyen MD, Stephen W. Waldo MD, Ehrin J. Armstrong MD, MSC, FSCAI

Purpose: To assess the intraprocedural and midterm outcomes of orbital atherectomy (OA) combined with drug-coated balloon (DCB) angioplasty for the treatment of calcified femoropopliteal disease.

AMERICAN HEART JOURNAL. Predicting long-term prognosis in stable peripheral artery disease with baseline functional capacity estimated by the Duke Activity Status Index

Vichai Senthong MD, Yuping Wu PhD, Stanley L Hazen MD, PhD, W. H. Wilson Tang MD

Background: The ability of a simple self-assessment tool for estimated functional capacity to predict long-term prognosis in patients with established peripheral artery disease (PAD) is unknown. We investigate whether subjective measurement of functional capacity estimated by using the Duke Activity Status Index (DASI) questionnaire predicts long-term prognosis in patients with established PAD.

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Clinical outcomes of balloon angioplasty alone versus nitinol stent implantation in patients with small femoropopliteal artery disease: Observations from the Retrospective Multicenter Analysis for Femoropopliteal Stenting (REAL‐FP)

Norihiko Kamioka MD, Yoshimitsu Soga MD, Shoichi Kuramitsu MD, Osamu Iida MD, Keisuke Hirano MD, Kenji Suzuki MD, Daizo Kawasaki MD, Terutoshi Yamaoka MD, Nobuhiro Suematsu MD, Yoshiaki Shintani MD, Yusuke Miyashita MD, Hiroki Takahashi MD, Taketsugu Tsuchiya MD, Norihiko Shinozaki MD, Shinya Okazaki MD, Kenji Ando MD

Objectives: We sought to assess whether balloon angioplasty (BA) alone for small femoropopliteal disease improved the outcome following endovascular therapy as compared with stent implantation.

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Patient‐level meta‐analysis of 999 claudicants undergoing primary femoropopliteal nitinol stent implantation

Krishna J. Rocha‐Singh MD, Joshua A. Beckman MD, Gary Ansel MD, Sean P. Lyden MD, Peter Schneider MD, Manish Mehta MD, Michael Dake MD, Christopher M. Mullin MS, Michael R. Jaff DO

The factors that impact the clinical effectiveness of bare nitinol stents in claudicants with symptomatic femoropopliteal atherosclerosis are incompletely known. The authors analyzed variables that may influence stent durability and provide a benchmark for their effectiveness. Data analyzed from six studies (999 patients) included baseline noninvasive hemodynamic tests, angiographic characteristics, ultrasound defined stent patency and target lesion revascularization through 12‐months. Baseline ankle‐brachial index and lesion length predicted stent patency and target lesion revascularization and when combined interacted significantly to better predict outcomes. This meta‐analysis provides an important comparator against which emerging therapies that treat claudicants with femoropopliteal atherosclerosis can be assessed.

JVIR. Twelve-month Results of the EverFlex Stent in the Superficial Femoral Artery

Steffen J. Diehl, MDemail address , Felix Gerblich, MD , Susanne Jochum, MD , Kurt Huck, MD , Michael Keese, MD , Stefan O. Schoenberg, MD , Maliha Sadick, MD

Purpose: To evaluate the clinical efficacy of EverFlex stents (length, 6–20 cm) for the treatment of peripheral artery disease (PAD) in the superficial femoral artery (SFA). Journal of Vascular and Interventional Radiology Volume 23, Issue 10 , Pages 1317-1322, October 2012. Copyright © SIR, 2012

JVIR. Current Clinical Practice in Postoperative Endovascular Aneurysm Repair Imaging Surveillance

Heiko Uthoff, MD , Constantino Peña, MD , Barry T. Katzen, MD , Ripal Gandhi, MD , James West , James F. Benenati, MD and Philipp Geisbüsch, MD

Purpose: To investigate the current clinical practice in postoperative endovascular aneurysm repair (EVAR) imaging surveillance. Journal of Vascular and Interventional Radiology Volume 23, Issue 9 , Pages 1152-1159.e6, September 2012. Copyright © SIR, 2012

01 septiembre 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Contrast induced‐acute kidney injury following peripheral angiography with carbon dioxide versus iodinated contrast media: A meta‐analysis and systematic review of current literature

Saad S. Ghumman MD, Jonathan Weinerman BS, Aazib Khan MD, Mubeen S. Cheema MD, Marlene Garcia MD, Daniel Levin MD, Rajeev Suri MD, Anand Prasad MD, FACC, FSCAI, RPVI

Objective: We conducted a meta‐analysis to compare the incidence of acute kidney injury (AKI) with carbon dioxide (CO2) versus iodinated contrast media (ICM).

01 febrero 2018

INTERNATIONAL JOURNAL OF CARDIOLOGY. Minimally invasive percutaneous transluminal renal artery stenting

Ken Kongoji, Takanobu Mitarai, Mizuho Kasahara, Hiroshi Yamazaki, Yuki Ishibashi, Kohei Koyama, Kihei Yoneyama, Yasuhiro Tanabe, Yoshihiro J. Akashi, Hideaki Yoshino

Background: Minimally invasive percutaneous transluminal renal artery stenting (MIPTRS) is a method that prevents complications to the greatest extent possible. The present study aimed to investigate the safety and efficacy of MIPTRS performed in cases of renal artery stenosis with an estimated glomerular filtration rate (eGFR) ≤ 45 mL/min.

14 septiembre 2016

CIRCULATION. Outcome of the Swedish Nationwide Abdominal Aortic Aneurysm Screening Program

Anders Wanhainen, Rebecka Hultgren, Anneli Linné, Jan Holst, Anders Gottsäter, Marcus Langenskiöld, Kristian Smidfelt, Martin Björck, Sverker Svensjö, On behalf of the Swedish Aneurysm Screening Study Group (SASS), Linda Lyttkens, Ewa Pihl, Tomas Wetterling, Per Kjellin, Ken Eliasson, Erik Wellander, Azin Narbani, Elisabet Skagius, Alexandra Hollsten, Martin Welander, Toste Länne, Bibbi Fröst, David Korman, Sven-Erik Persson, Birgitta Sigvant, Thomas Troëng, Markus Palm, Eva Ansgarius, Nils-Peter Gilgen, Christina Sjöström, Khatereh Djavani Gidlund, Peter Danielsson, Adam Bersztel and Tomas Jonasson

Background: A general abdominal aortic aneurysm (AAA) screening program, targeting 65-year-old men, has gradually been introduced in Sweden since 2006 and reached nationwide coverage in 2015. The aim of this study was to determine the outcome of this program.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.